Breast Cancer Trial, Not Yet Recruiting NCT07582770 Sponsor: European Institute of Oncology Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07582770
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 18 and 65 years old
  • People who have previously been diagnosed with non-metastatic breast cancer (this applies to the breast cancer survivor group only)
  • People who finished chemotherapy at least 6 months ago and no more than 36 months ago, if chemotherapy was planned (this applies to the breast cancer survivor group only)
  • People who understand Italian and are able to give their informed consent to participate

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have cancer that has spread to the brain, or who have previously had radiation therapy to the brain (this applies to the breast cancer survivor group only)
  • People who have been diagnosed with another type of cancer in addition to breast cancer (this applies to the breast cancer survivor group only)
  • People who have previously been diagnosed with a malignant cancer of any kind (this applies to the control group only)
  • People who have a history of brain damage that has left lasting neurological effects
  • People who have had, or currently have, serious neurological conditions
  • People who have severe psychiatric conditions
  • People who have ongoing health conditions affecting the whole body that could interfere with thinking and cognitive abilities
  • People who are taking medications that strongly affect thinking or cognitive function, and whose dose has not been stable for at least 4 weeks before joining the trial
  • People who have vision or hearing difficulties that are not adequately corrected with glasses, hearing aids, or other means
  • People who have any disability that could affect how well they are able to complete cognitive tests

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0257489731

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
European Institute of Oncology
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 April 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Validation of a second-level cognitive test battery to be employed for clinical use for the detection of CRCI in breast cancer survivors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov